Lucy To
CIK: 0002032049
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SABS
SAB Biotherapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About To Lucy
To Lucy (SEC CIK 0002032049) files insider reports with the SEC as Officer of SAB Biotherapeutics, Inc. (SABS).
Signal8 holds 2 ownership filings by To Lucy, all Form 4s, filed between Aug 28, 2025 and Feb 5, 2026. Those filings report 2 transactions, from Aug 26, 2025 to Feb 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on To Lucy's filings is in MIAMI BEACH, FL.
Recent filings by To Lucy
Other insiders filing for SAB Biotherapeutics, Inc. (SABS)
- Kropotova Alexandra, CHIEF MEDICAL OFFICER
- Sullivan Eddie Joe, PRESIDENT
- Reich Samuel J, CEO
- Bausch Christoph Lawrence, CHIEF OPERATING OFFICER
- Jain Rita, Director
- ZACCARDELLI DAVID, Director